Welcome to our dedicated page for Albemarle news (Ticker: ALB), a resource for investors and traders seeking the latest updates and insights on Albemarle stock.
Albemarle Corporation reports news on its role as a global producer of lithium and bromine used in mobility, energy, connectivity and health applications. Company updates commonly cover Energy Storage and Specialties performance, lithium market pricing and volumes, bromine-based solutions, operational productivity, and cash generation.
Recurring developments also include quarterly earnings releases, common stock dividends, debt tender offers and note redemptions, board and committee appointments, and portfolio actions. Recent corporate updates include the completed sale of a controlling stake in Ketjen's refining catalyst solutions business, Albemarle's retained minority interest in Ketjen, and the integration of Performance Catalyst Solutions into Albemarle's product portfolio.
Albemarle Corporation (NYSE: ALB), a key player in mobility, energy, connectivity, and health, has scheduled the release of its first-quarter 2023 earnings on May 3, 2023, post-market. A conference call will take place the following day, May 4, 2023, at 9:00 a.m. ET to discuss the results. This call will be accessible via the company's website and telephonically. Relevant access codes and phone numbers for participants are provided. The company encourages usage of the webcast for efficiency. An online replay will be available for a year, with a telephone replay for seven days. Albemarle specializes in lithium and bromine, crucial for various industries, and is committed to sustainability and safety.
Albemarle Corporation (NYSE: ALB) announced a non-binding proposal to acquire Liontown Resources (ASX: LTR) for A$2.50 (US$1.66) per share, valuing Liontown at A$5.2 billion (US$3.4 billion). This offer represents a significant premium: 63% over Liontown's closing price on March 27, 2023, and 69% over the 30-day VWAP. Albemarle aims to enhance liquidity for Liontown shareholders and mitigate risks associated with future project developments, particularly the Kathleen Valley project. The proposal has received unanimous approval from Albemarle's Board and is backed by financial support from J.P. Morgan.
Albemarle Corporation (NYSE: ALB) plans to invest at least $1.3 billion in a new lithium hydroxide Mega-Flex facility in Chester County, South Carolina. This facility aims to meet growing demand for electric vehicles and lithium-ion batteries, with an anticipated annual production of 50,000 metric tons of battery-grade lithium hydroxide, expandable to 100,000 metric tons. The project is expected to create over 300 jobs with an average salary of $93,000, alongside more than 1,500 construction jobs. Construction is slated to begin in late 2024.
On February 23, 2023, Albemarle Corporation (NYSE: ALB) announced a quarterly dividend of $0.40 per share, marking the 29th consecutive year of dividend increases. The dividend, with an annualized rate of $1.60, will be payable on April 3, 2023, to shareholders on record as of March 17, 2023. This dividend reflects the company's commitment to returning value to shareholders while emphasizing its leadership in transforming resources into critical ingredients for multiple sectors, including energy and health.
Albemarle Corporation (NYSE: ALB) has signed definitive agreements with Mineral Resources Limited (ASX: MIN) to restructure their MARBL lithium joint venture in Australia and for MinRes to invest in Albemarle's conversion assets in China. Upon closure, Albemarle will increase its stake in the Kemerton processing plant from 60% to 85%, while MinRes will raise its interest in the Wodgina Lithium Mine from 40% to 50%. In China, MinRes will acquire a 50% interest in Albemarle's Qinzhou and Meishan plants. These agreements aim to enhance growth opportunities and improve resource management, essential for meeting rising lithium-ion battery demands.
Albemarle Corporation (NYSE: ALB), a leader in essential resources like lithium and bromine, announced that President and CEO Kent Masters will present at the BMO Capital Markets 2023 Investor Conference on February 27, 2023, at 1:30 PM ET. The presentation will highlight the company's commitment to transforming resources into critical ingredients for mobility, energy, connectivity, and health. A live webcast will be available on the investor relations section of Albemarle's website, with a replay accessible for 30 days afterward. For more details, visit investors.albemarle.com.
Albemarle Corporation (NYSE: ALB) reported impressive fourth-quarter and full-year 2022 results, highlighting net sales of $2.6 billion, up 193%, and net income of $1.1 billion, equating to $9.60 per diluted share. The adjusted diluted EPS surged 753% to $8.62. For full-year 2022, net sales exceeded $7 billion, doubling 2021 figures, while adjusted EBITDA reached approximately $3.5 billion, nearly quadrupling the previous year. Albemarle anticipates 2023 net sales between $11.3 - $12.9 billion and adjusted EBITDA of $4.2 - $5.1 billion. The company is poised for transformative growth with projections for 2027 net sales reaching $17.6 - $19.3 billion, driven by a disciplined capital allocation and increasing demand for lithium.
Albemarle Corporation (NYSE: ALB) has launched Ketjen, a wholly owned subsidiary focused on advanced catalyst solutions for the petrochemical, refining, and specialty chemicals industries. The brand, formally introduced in January 2023, aims to enhance customer support in energy transitions, offering tailored solutions in fluidized catalytic cracking, clean fuels, hydro-processing, and organometallics. Ketjen will provide a range of performance catalysts through three divisions while leveraging Albemarle's existing catalyst team. This initiative is expected to strengthen Albemarle's position as a partner-of-choice in the industry.
Albemarle Corporation (NYSE: ALB) will host its virtual 2023 Strategy Update on Jan. 24, 2023, from 9:00 a.m. to 10:45 a.m. ET. Key executives will present corporate strategy, preliminary 2022 results, and 2023 guidance. Highlights include an anticipated net sales range of $11.3 - $12.9 billion and an adjusted EBITDA of $4.2 - $5.1 billion for FY 2023. The company aims for long-term growth, especially in Energy Storage, with a 5-Year CAGR target of 25%-27%. Albemarle exceeded previous projections in 2022 and focuses on enhancing sustainability and operational performance. The event will be accessible via their website.
Albemarle Corporation (NYSE: ALB) will announce its fourth-quarter 2022 earnings on February 15, 2023, after the NYSE closes. A conference call to discuss the results is scheduled for February 16, 2023, at 9:00 a.m. ET. Investors can access the call via Albemarle's website or by phone. The replay will be available for 12 months online and 7 days via phone. Albemarle is a global specialty chemicals leader with significant positions in lithium, bromine, and catalysts, dedicated to sustainable practices across various critical industries.